Literature DB >> 29349764

Sexual Function Post-Breast Cancer.

Lauren Streicher1, James A Simon2,3.   

Abstract

The consequences of estrogen deprivation and therapeutic interventions such as radiation, chemotherapy and surgery have a significant negative impact on libido, sexual arousal, orgasmic function and the ability to have pleasurable intercourse. Evaluation and treatment of female sexual dysfunction is a significant unmet need in the breast cancer survivor in spite of the availability of safe and effective treatments.

Entities:  

Keywords:  DHEA; Dyspareunia; Female sexual dysfunction; Fractional CO2 laser; Genitourinary syndrome of menopause; Hypoactive sexual desire disorder; Ospemifene; Prasterone; Vaginal estrogen

Mesh：

Substances：

Year:  2018        PMID： 29349764     DOI： 10.1007/978-3-319-70197-4_11

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


  4 in total

1.  Obese Breast Cancer Patients and Survivors: Management Considerations.

Authors:  Jennifer Y Sheng; Dipali Sharma; Gerald Jerome; Cesar Augusto Santa-Maria
Journal:  Oncology (Williston Park)       Date:  2018-08-15       Impact factor: 2.533

2.  Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.

Authors:  Lucie Veron; Delphine Wehrer; Gisèle Annerose-Zéphir; Voichita Suciu; Suzette Delaloge; Barbara Pistilli; Dan Chaltiel; Patricia Pautier
Journal:  Breast Cancer Res Treat       Date:  2021-04-23       Impact factor: 4.872

3.  Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey.

Authors:  Solveig K Smedsland; Kathrine F Vandraas; Synne K Bøhn; Alv A Dahl; Cecilie E Kiserud; Mette Brekke; Ragnhild S Falk; Kristin V Reinertsen
Journal:  Breast Cancer Res Treat       Date:  2022-02-28       Impact factor: 4.872

Review 4.  Sexual dysfunction as a challenge in treated breast cancer: in-depth analysis and risk assessment to improve individual outcomes.

Authors:  Abraham Hernández-Blanquisett; Valeria Quintero-Carreño; Angelina Álvarez-Londoño; María Cristina Martínez-Ávila; Raissa Diaz-Cáceres
Journal:  Front Oncol       Date:  2022-08-02       Impact factor: 5.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.